Kevin Ward, MD
Director
Weil Institute
Professor of Emergency Medicine
Professor of Biomedical Engineering
[email protected]

Available to mentor

Kevin Ward, MD
Professor
  • About
  • Center Memberships
  • Recent Publications
  • About

    Dr. Ward is a Professor in the Departments of Emergency Medicine and Biomedical Engineering at the University of Michigan. He received his B.S. in Physiology from Louisiana State University in Baton Rouge in 1985 and his degree in medicine from Tulane University in New Orleans, LA in 1989. Dr. Ward then completed a residency in Emergency Medicine at the University of Pittsburgh followed by a Resuscitation Research fellowship at the Ohio State University in Columbus, OH. Prior to joining the University of Michigan in 2012, Dr. Ward was Professor and Associate Chair of Emergency Medicine at Virginia Commonwealth University (VCU) were he also founded and directed the VCU Reanimation Engineering Science Center (VCURES).

    Dr. Ward’s research interests span the field of critical illness and injury ranging from combat casualty care to the intensive care unit. His approach is to develop and leverage broad platform technologies capable of use throughout all echelons of care of the critically ill and injured as well as in all age groups. Dr. Ward’s work has been funded by the NIH, Department of Defense, NSF, and industry. He has published over 200 peer-reviewed articles and book chapters. He is the recipient of the Society of Academic Emergency Medicine’s Excellence in Research Award as well as the American College of Emergency Physicians Outstanding Contributions in Research Award.

    Dr. Ward’s passion is in creating programs which encourage true integration across the disciplines of medicine, engineering, data sciences, and entrepreneurship that accelerate discovery to true patient impact. In addition to founding the Max Harry Weil Institute for Critical Care Research and Innovation(link is external)(link is external), he led the design and implementation of Michigan Medicine’s Fast Forward Medical Innovation(link is external)(link is external) (FFMI) program and served as its inaugural Executive Director from 2013-2018. He is a serial innovator and entrepreneur in the field of emergency and critical care medicine and the recipient of Innovation and Commercialization awards from Virginia Commonwealth University, the University of Michigan Medical School, and the Department of Defense.

    In collaboration with the U.S. Army and its Joint Special Operations Training Medical Center, Dr. Ward developed and medically directed special training programs, which have been responsible for providing clinical training to over 1000 Special Operation Combat Medics. For this work, Dr. Ward was awarded a Certificate for Patriotic Civilian Service by the Department of the Army and the Joint Special Operations Training Center. Dr. Ward also served as a Lieutenant Colonel in the U.S. Army Medical Corps and its 948th Forward Resuscitation Surgical Team deploying to Afghanistan in support of Operation Freedom’s Sentinel and the 10th Special Forces Group (Airborne).

    Serving on numerous editorial and review boards in the field of resuscitation, emergency and critical care medicine, Dr. Ward also serves on the executive committee for the Trauma Hemostasis and Oxygenation Research (link is external) (link is external) (THOR).

    Administrative Contact:
    Denise Wieck
    [email protected]

    Center Memberships
    • Center Member
      Center for Computational Medicine and Bioinformatics
    • Center Member
      Center for Integrative Research in Critical Care
    Recent Publications See All Publications
    • Journal Article
      Use of a continuous single lead electrocardiogram analytic to predict patient deterioration requiring rapid response team activation.
      Lee S, Benson B, Belle A, Medlin RP, Jerkins D, Goss F, Khanna AK, DeVita MA, Ward KR. PLOS Digit Health, 2024 Oct; 3 (10): e0000465 DOI:10.1371/journal.pdig.0000465
      PMID: 39446712
    • Journal Article
      Blood failure: traumatic hemorrhage and the interconnections between oxygen debt, endotheliopathy, and coagulopathy.
      Lee JH, Ward KR. Clin Exp Emerg Med, 2024 Mar; 11 (1): 9 - 21. DOI:10.15441/ceem.23.127
      PMID: 38018069
    • Journal Article
      Life Over Limb: Why Not Both? Revisiting Tourniquet Practices Based on Lessons Learned From the War in Ukraine.
      Patterson JL, Bryan RT, Turconi M, Leiner A, Plackett TP, Rhodes LL, Sciulli L, Donnelly S, Reynolds CW, Leanza J, Fisher AD, Kushnir T, Artemenko V, Ward KR, Holcomb JB, Schmitzberger FF. J Spec Oper Med, 2024 Mar 13; DOI:10.55460/V057-2PCH
      PMID: 38300880
    • Patent
      Microfluidic device for size and deformability measurements and applications thereof
      Burns M, Krausz A, Mena S, De Beer P, Ward K, Korley F. 2024 Feb 13;
    • Preprint
      Use of a Continuous Single Lead Electrocardiogram Analytic to Predict Patient Deterioration Requiring Rapid Response Team Activation
      Lee S, Benson B, Belle A, Medlin RP, Jerkins D, Goss F, Khanna AK, DeVita MA, Ward KR. medRxiv, DOI:10.1101/2024.02.09.24302599
    • Journal Article
      367: PREDICTIVE NATURE OF A HEMODYNAMIC INDICATOR BY DURATION OF INSTABILITY IN CRITICALLY ILL PATIENTS
      Benson B, Lee S, Belle A, Ward K, Khanna AK. Critical Care Medicine, 2024 Jan; 52 (1): s158 - s158. DOI:10.1097/01.ccm.0000999652.24730.bb
    • Journal Article
      Collaborative strategies for deploying artificial intelligence to complement physician diagnoses of acute respiratory distress syndrome.
      Farzaneh N, Ansari S, Lee E, Ward KR, Sjoding MW. NPJ Digit Med, 2023 Apr 8; 6 (1): 62 DOI:10.1038/s41746-023-00797-9
      PMID: 37031252
    • Journal Article
      Effect of percutaneous ventricular assisted device on post-cardiac arrest myocardial dysfunction in swine model with prolonged cardiac arrest.
      Nakashima T, Hakam Tiba M, McCracken BM, Hsu CH, Gottula AL, Greer NL, Cramer TA, Sutton NR, Ward KR, Neumar RW. Resuscitation, 2023 Dec; 193: 110010 DOI:10.1016/j.resuscitation.2023.110010
      PMID: 37884220
    Featured News & Stories Nurse viewing AHI interface displayed on a laptop computer monitor.
    Research News
    Fifth Eye’s AHI-PI Demonstrates Ability to Detect Patient Deterioration Prior to Rapid Response Team Events: New Study Published in PLOS Digital Health
    Fifth Eye, Inc., a spin-off of the Max Harry Weil Institute for Critical Care Research and Innovation, announced the publication of a new study in the peer-reviewed journal, PLOS Digital Health, demonstrating the power of the company’s Analytic for Hemodynamic Instability-Predictive Indicator (AHI-PI) in predicting patient deterioration before a Rapid Response Team (RRT) event. An RRT event occurs when a dedicated team of healthcare professionals is mobilized to respond to a patient's critical deterioration. Detecting patient deterioration early is crucial, as it provides clinicians with more time to intervene, potentially preventing crises, improving patient outcomes, and reducing hospital costs.
    Close-up of multiple IV fluid bags in an operating room
    Research News
    U-M & Michigan Medicine collaboration addresses IV fluid shortage in less than 24 hours
    In a rapid response to the dire shortage of intravenous (IV) fluid bags currently affecting hospitals nationwide, investigators from the University of Michigan (U-M) Max Harry Weil Institute for Critical Care Research and Innovation and U-M Precision Health have developed a novel projection model to help U-M Health teams conserve critical medical supplies.
    Illustration of the BioHelmet depicting clean air flowing in via the helmet's shroud and contaminated air flowing out through the attached HEPA filter and waist-mounted fan unit.
    Research News
    Weil Institute spin-off InspireRx awarded over $2 million for patient isolation system guarding against airborne infections
    InspireRx, LLC., a spin-off company of the University of Michigan (U-M) Max Harry Weil Institute for Critical Care Research and Innovation, received over $2 million in Small Business Innovation Research (SBIR) grants to support further development of the AerosolVE BioHelmet, a compact negative pressure system for patients with highly contagious airborne respiratory infections such as COVID-19.
    Members of the Weil Institute Data Science and Commercialization teams stand at their table display during Celebrate Invention 2023.
    Research News
    Weil Institute to be Featured at 2024 Celebrate Invention!
    The Weil Institute will have a major presence at this year's Celebrate Invention event, hosted by U-M Innovation Partnerships. Dr. Kevin Ward, Executive Director of the Institute, will speak as the 2024 Distinguished University Innovator of the Year. Precision Trauma and RUA Diagnostics, two Weil Institute partners, will display a novel tourniquet and breath analysis technology, respectively.